Technical Analysis for LMNX - Luminex Corporation

Grade Last Price % Change Price Change
grade F 23.88 -1.32% -0.32
LMNX closed down 1.32 percent on Friday, March 22, 2019, on 1.37 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical LMNX trend table...

Date Alert Name Type % Chg
Mar 22 Outside Day Range Expansion 0.00%
Mar 19 Slingshot Bearish Bearish Swing Setup -2.69%
Mar 18 Hammer Candlestick Bullish -0.50%
Mar 18 Stochastic Buy Signal Bullish -0.50%
Mar 18 Lizard Bullish Bullish Day Trade Setup -0.50%
Mar 18 Pocket Pivot Bullish Swing Setup -0.50%
Mar 18 Doji - Bullish? Reversal -0.50%
Mar 18 Oversold Stochastic Weakness -0.50%
Mar 15 Doji - Bullish? Reversal -0.42%
Mar 15 Outside Day Range Expansion -0.42%

Older signals for LMNX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres; and MultiCode technology used for real-time polymerase chain reaction (PCR) and multiplexed PCR assays, as well as automation and robotics in the field of dry sample handling. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment's products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company's proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company has a collaboration and license agreement with Merck & Co., Inc. to develop a companion diagnostic device. Luminex Corporation was founded in 1995 and is headquartered in Austin, Texas.
Life Sciences Pharmaceutical Chemical Natural Sciences Infectious Disease Laboratory Techniques Digital Signal Processing DSP Luminex Corporation Real Time Polymerase Chain Reaction
Is LMNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 35.37
52 Week Low 19.2
Average Volume 347,146
200-Day Moving Average 27.7071
50-Day Moving Average 25.493
20-Day Moving Average 24.6435
10-Day Moving Average 24.171
Average True Range 0.7036
ADX 21.47
+DI 19.2105
-DI 25.8668
Chandelier Exit (Long, 3 ATRs ) 24.7092
Chandelier Exit (Short, 3 ATRs ) 25.3208
Upper Bollinger Band 26.2146
Lower Bollinger Band 23.0724
Percent B (%b) 0.26
BandWidth 12.750624
MACD Line -0.411
MACD Signal Line -0.3996
MACD Histogram -0.0114
Fundamentals Value
Market Cap 1.05 Billion
Num Shares 44.1 Million
EPS 0.32
Price-to-Earnings (P/E) Ratio 74.63
Price-to-Sales 2.97
Price-to-Book 2.08
PEG Ratio 0.67
Dividend 0.24
Dividend Yield 1.01%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.01
Resistance 3 (R3) 25.13 24.87 24.82
Resistance 2 (R2) 24.87 24.59 24.81 24.75
Resistance 1 (R1) 24.38 24.41 24.25 24.26 24.69
Pivot Point 24.12 24.12 24.06 24.06 24.12
Support 1 (S1) 23.63 23.84 23.50 23.51 23.07
Support 2 (S2) 23.37 23.66 23.31 23.01
Support 3 (S3) 22.88 23.37 22.94
Support 4 (S4) 22.76